Custom Manufacturing Process For 4-Fluoro-3-Chloro-Aniline High-Purity Grade
- Industrial-scale synthesis of 3-Chloro-4-fluoroaniline achieving ≥99.5% purity via catalytic hydrogenation or diazotization-fluorination routes.
- Optimized reaction parameters ensure high yield (>94%), minimal dehalogenation, and compliance with pharmaceutical intermediate standards.
- NINGBO INNO PHARMCHEM CO.,LTD. offers bulk supply with full COA documentation, supporting GMP-aligned procurement for API and agrochemical sectors.
As a critical building block in the synthesis of fluoroquinolone antibiotics like ciprofloxacin and norfloxacin, 3-Chloro-4-fluoroaniline (also known as para-fluoro-meta-chloroaniline or Benzenamine, 3-chloro-4-fluoro) demands stringent control over purity, isomeric integrity, and trace impurities. Global pharmaceutical and agrochemical manufacturers require a reliable, scalable, and technically robust custom manufacturing process that ensures consistent industrial purity while minimizing hazardous byproducts. NINGBO INNO PHARMCHEM CO.,LTD. has engineered two validated synthesis routes—catalytic hydrogenation and diazotization-fluorination—to meet these exacting standards for bulk commercial supply.
Validated Synthesis Routes for High-Purity CHLOROFLUOROANILINE
The production of 4-fluoro-3-chloro-aniline hinges on selecting a route that balances yield, selectivity, environmental impact, and cost-efficiency at scale. Two primary pathways have been industrialized:
Route A: Catalytic Hydrogenation of 3-Chloro-4-fluoronitrobenzene
This method leverages heterogeneous catalysis under controlled hydrogen pressure to reduce the nitro group without cleaving the C–Cl or C–F bonds—a common challenge in halogenated anilines. Using a 1% Pt/C catalyst, the reaction proceeds under mild conditions (50–100°C, 0.1–5 MPa H₂) with no organic solvent required, significantly reducing waste and simplifying downstream processing.
- Raw Material: 3-Chloro-4-fluoronitrobenzene (high-purity grade)
- Catalyst Loading: 1% Pt/C at mass ratio of 200:1 to 400:1 (substrate:catalyst)
- Conversion & Yield: >99% conversion, 94–96% isolated yield
- Purity: ≥99.5% after vacuum rectification
This route is particularly favored for its atom economy, absence of iron sludge or acid mist, and compatibility with continuous fixed-bed reactor systems—ideal for multi-ton campaigns.
Route B: Diazotization-Fluorination of 3-Chloroaniline
Adapted from patent literature (e.g., CN106349084B), this three-step sequence begins with 3-chloroaniline and introduces fluorine via a Balz-Schiemann-type transformation:
- Diazotization: 3-Chloroaniline + NaNO₂ + dilute HCl → 3-chloro-4-nitrosoaniline
- Fluorination: Reaction with fluorinating agent (e.g., in fluoroform medium) at 50–70°C
- Hydrolysis & Purification: Acidic hydrolysis followed by pH adjustment (NaOH to pH 10–11), chloroform extraction, and vacuum distillation
While more complex, this route uses inexpensive starting materials and achieves final purity of 99.5–99.8%. It is suitable when nitro precursors are less accessible or when integrated into existing aniline-based production lines.
Industrial Purity Assurance & Analytical Control
For pharmaceutical intermediates, purity alone is insufficient—impurity profiles must be rigorously controlled. NINGBO INNO PHARMCHEM CO.,LTD. implements in-process analytical testing (IPAT) using HPLC-UV and GC-MS at critical stages to monitor:
- Residual solvents (<10 ppm)
- Isomeric impurities (e.g., 2-chloro-4-fluoroaniline)
- Dehalogenated byproducts (e.g., 4-fluoroaniline)
- Heavy metals (Pt, Fe < 5 ppm)
Every batch is accompanied by a comprehensive Certificate of Analysis (COA), detailing assay, water content (KF), melting point, and spectral data (¹⁹F NMR, IR). This ensures seamless regulatory filing support under ICH Q7 guidelines.
Bulk Procurement & Commercial Advantages
When sourcing high-purity 3-Chloro-4-fluoroaniline, buyers benefit from NINGBO INNO PHARMCHEM CO.,LTD.’s vertically integrated manufacturing platform in China, capable of delivering multi-metric-ton quantities with lead times under 8 weeks. The company’s dual-route flexibility allows rapid adaptation to raw material market fluctuations, ensuring stable bulk price structures even amid supply chain volatility.
As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. combines process chemistry excellence with ISO 9001-certified quality systems, offering custom packaging (drums, IBCs), export documentation, and technical dossiers tailored to client regulatory needs.
Comparative Performance of Synthesis Routes
| Synthesis Parameter | Catalytic Hydrogenation Route | Diazotization-Fluorination Route |
|---|---|---|
| Starting Material | 3-Chloro-4-fluoronitrobenzene | 3-Chloroaniline |
| Catalyst/Reagents | 1% Pt/C, H₂ gas | NaNO₂, HCl, fluorinating agent |
| Reaction Steps | 1 (single pot) | 3 |
| Organic Solvent Use | None | Moderate (fluoroform, chloroform) |
| Typical Yield | 94–96% | 88–92% |
| Final Purity | ≥99.5% | 99.5–99.8% |
| Waste Profile | Low (catalyst recyclable) | Moderate (acidic aqueous waste) |
| Scale-Up Readiness | Excellent (continuous flow compatible) | Good (batch only) |
Both routes deliver pharma-grade 3-Chloro-4-fluorobenzenamine, but the hydrogenation path is increasingly preferred for sustainability and operational simplicity in modern API manufacturing.
Conclusion
For companies requiring a dependable, high-yield, and compliant source of 4-fluoro-3-chloro-aniline, NINGBO INNO PHARMCHEM CO.,LTD. stands out as a strategic partner. With dual validated synthesis routes, rigorous quality controls, and bulk manufacturing capacity, the company ensures consistent delivery of this essential fluoro-chloro aromatic amine to global markets. Technical inquiries and sample requests are supported by dedicated process chemists to facilitate seamless integration into your supply chain.